Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Østergaard

Showing results (211-220 of 403) with videos related to

Pageof 41
Sort By:
Seminars in Arthritis and Rheumatism|March 30, 2021
Volumetric quantitative measurement of hip effusions by manual versus automated artificial intelligence techniques: An OMERACT preliminary validation studyJacob L Jaremko, Banafshe Felfeliyan, Abhilash Hareendranathan, et al.
The Journal of Rheumatology|April 16, 2021
Development and Validation of 3 Preliminary MRI Sacroiliac Joint Composite Structural Damage Scores in a 5-year Longitudinal Axial Spondyloarthritis StudyMarie Wetterslev, Mikkel Østergaard, Inge J Sørensen, et al.
Arthritis Research & Therapy|June 23, 2022
Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back painHelena Port, Signe Holm Nielsen, Sofie Falkenløve Madsen, et al.
Arthritis and Rheumatism|May 28, 2010
Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II studyMikkel Østergaard, Bo Baslund, William Rigby, et al.
Arthritis Research & Therapy|November 1, 2014
CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patientsChristian Gytz Ammitzbøll, Rudi Steffensen, Martin Bøgsted, et al.
Annals of the Rheumatic Diseases|May 26, 2026
Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritisMikkel Østergaard, Robert G W Lambert, Walter P Maksymowych, et al.
RMD Open|April 10, 2026
Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE)Nora Vladimirova, Mikkel Østergaard, Sengül Seven, et al.
RMD Open|January 6, 2026
Prevalence and anatomical distribution of MRI lesions in axSpA and differences between patients with and without peripheral involvement: results from the ASAS classification cohortBayram Farisogullari, Stephanie Wichuk, Xenofon Baraliakos, et al.
European Radiology|February 1, 2015
Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated?Wouter Stomp, Annemarie Krabben, Désirée van der Heijde, et al.
Arthritis Research & Therapy|January 8, 2009
MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damageYu M Tan, Mikkel Østergaard, Anthony Doyle, et al.
Pageof 41

Showing results (211-220 of 403) with videos related to

Sort By:
Pageof 41
Seminars in Arthritis and Rheumatism|March 30, 2021
Volumetric quantitative measurement of hip effusions by manual versus automated artificial intelligence techniques: An OMERACT preliminary validation studyJacob L Jaremko, Banafshe Felfeliyan, Abhilash Hareendranathan, et al.
The Journal of Rheumatology|April 16, 2021
Development and Validation of 3 Preliminary MRI Sacroiliac Joint Composite Structural Damage Scores in a 5-year Longitudinal Axial Spondyloarthritis StudyMarie Wetterslev, Mikkel Østergaard, Inge J Sørensen, et al.
Arthritis Research & Therapy|June 23, 2022
Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back painHelena Port, Signe Holm Nielsen, Sofie Falkenløve Madsen, et al.
Arthritis and Rheumatism|May 28, 2010
Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II studyMikkel Østergaard, Bo Baslund, William Rigby, et al.
Arthritis Research & Therapy|November 1, 2014
CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patientsChristian Gytz Ammitzbøll, Rudi Steffensen, Martin Bøgsted, et al.
Annals of the Rheumatic Diseases|May 26, 2026
Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritisMikkel Østergaard, Robert G W Lambert, Walter P Maksymowych, et al.
RMD Open|April 10, 2026
Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE)Nora Vladimirova, Mikkel Østergaard, Sengül Seven, et al.
RMD Open|January 6, 2026
Prevalence and anatomical distribution of MRI lesions in axSpA and differences between patients with and without peripheral involvement: results from the ASAS classification cohortBayram Farisogullari, Stephanie Wichuk, Xenofon Baraliakos, et al.
European Radiology|February 1, 2015
Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated?Wouter Stomp, Annemarie Krabben, Désirée van der Heijde, et al.
Arthritis Research & Therapy|January 8, 2009
MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damageYu M Tan, Mikkel Østergaard, Anthony Doyle, et al.
Pageof 41